NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 57 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2016. The put-call ratio across all filers is 6.52 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $15,000 | -31.8% | 41,403 | -31.1% | 0.00% | -50.0% |
| Q4 2017 | $22,000 | -12.0% | 60,066 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $25,000 | -19.4% | 60,066 | 0.0% | 0.00% | -20.0% |
| Q2 2017 | $31,000 | -11.4% | 60,066 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $35,000 | -7.9% | 60,066 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $38,000 | -30.9% | 60,066 | 0.0% | 0.01% | -50.0% |
| Q3 2016 | $55,000 | -97.6% | 60,066 | -50.0% | 0.01% | -96.1% |
| Q2 2016 | $2,257,000 | +3600.0% | 120,132 | +84.6% | 0.26% | +1506.2% |
| Q1 2016 | $61,000 | -29.9% | 65,066 | 0.0% | 0.02% | -23.8% |
| Q4 2015 | $87,000 | -41.2% | 65,066 | 0.0% | 0.02% | -41.7% |
| Q3 2015 | $148,000 | +41.0% | 65,066 | 0.0% | 0.04% | +176.9% |
| Q2 2015 | $105,000 | +1.9% | 65,066 | 0.0% | 0.01% | +8.3% |
| Q1 2015 | $103,000 | -16.3% | 65,066 | 0.0% | 0.01% | +50.0% |
| Q4 2014 | $123,000 | +32.3% | 65,066 | -7.7% | 0.01% | +33.3% |
| Q3 2014 | $93,000 | -10.6% | 70,500 | 0.0% | 0.01% | -14.3% |
| Q2 2014 | $104,000 | -20.0% | 70,500 | 0.0% | 0.01% | -22.2% |
| Q1 2014 | $130,000 | -11.0% | 70,500 | 0.0% | 0.01% | -40.0% |
| Q4 2013 | $146,000 | -21.9% | 70,500 | 0.0% | 0.02% | +15.4% |
| Q3 2013 | $187,000 | -0.5% | 70,500 | 0.0% | 0.01% | -7.1% |
| Q2 2013 | $188,000 | – | 70,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|